Milan - Delayed Quote EUR

Gilead Sciences, Inc. (1GILD.MI)

Compare
93.84
+1.58
+(1.71%)
At close: January 31 at 10:00:18 AM GMT+1
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
28,299,000.00
27,116,000.00
27,281,000.00
27,305,000.00
24,689,000.00
Cost of Revenue
6,760,000.00
6,498,000.00
5,657,000.00
6,601,000.00
4,572,000.00
Gross Profit
21,539,000.00
20,618,000.00
21,624,000.00
20,704,000.00
20,117,000.00
Operating Expense
11,466,000.00
11,808,000.00
10,650,000.00
9,847,000.00
10,190,000.00
Operating Income
10,073,000.00
8,810,000.00
10,974,000.00
10,857,000.00
9,927,000.00
Net Non Operating Interest Income Expense
-1,058,000.00
-944,000.00
-935,000.00
-1,001,000.00
-984,000.00
Other Income Expense
-8,839,000.00
-1,007,000.00
-4,225,000.00
-1,578,000.00
-7,274,000.00
Pretax Income
176,000.00
6,859,000.00
5,814,000.00
8,278,000.00
1,669,000.00
Tax Provision
63,000.00
1,247,000.00
1,248,000.00
2,077,000.00
1,580,000.00
Net Income Common Stockholders
126,000.00
5,665,000.00
4,592,000.00
6,225,000.00
123,000.00
Diluted NI Available to Com Stockholders
126,000.00
5,665,000.00
4,592,000.00
6,225,000.00
123,000.00
Basic EPS
0.11
4.54
3.66
4.96
0.10
Diluted EPS
0.09
4.50
3.64
4.93
0.10
Basic Average Shares
1,246,500.00
1,248,000.00
1,255,000.00
1,256,000.00
1,257,000.00
Diluted Average Shares
1,249,000.00
1,258,000.00
1,262,000.00
1,262,000.00
1,263,000.00
Total Operating Income as Reported
822,000.00
7,605,000.00
7,330,000.00
9,918,000.00
4,071,000.00
Total Expenses
18,226,000.00
18,306,000.00
16,307,000.00
16,448,000.00
14,762,000.00
Net Income from Continuing & Discontinued Operation
126,000.00
5,665,000.00
4,592,000.00
6,225,000.00
123,000.00
Normalized Income
5,932,017.05
6,650,690.00
7,452,540.00
6,928,311.00
4,397,880.00
Interest Expense
980,000.00
944,000.00
935,000.00
1,001,000.00
984,000.00
Net Interest Income
-1,058,000.00
-944,000.00
-935,000.00
-1,001,000.00
-984,000.00
EBIT
1,156,000.00
7,803,000.00
6,749,000.00
9,279,000.00
2,653,000.00
EBITDA
3,918,000.00
10,496,000.00
8,852,000.00
11,329,000.00
4,133,000.00
Reconciled Cost of Revenue
6,760,000.00
6,498,000.00
5,657,000.00
6,601,000.00
4,572,000.00
Reconciled Depreciation
2,762,000.00
2,693,000.00
2,103,000.00
2,050,000.00
1,480,000.00
Net Income from Continuing Operation Net Minority Interest
126,000.00
5,665,000.00
4,592,000.00
6,225,000.00
123,000.00
Total Unusual Items Excluding Goodwill
-9,043,000.00
-1,205,000.00
-3,644,000.00
-939,000.00
-5,856,000.00
Total Unusual Items
-9,043,000.00
-1,205,000.00
-3,644,000.00
-939,000.00
-5,856,000.00
Normalized EBITDA
12,961,000.00
11,701,000.00
12,496,000.00
12,268,000.00
9,989,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-3,236,982.95
-219,310.00
-783,460.00
-235,689.00
-1,581,120.00
12/31/2020 - 10/23/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade